Sign up online today & collaborate
or click here to find out more
Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position even further, by presenting good results from a Phase III of its stem cell therapy treating Crohn’s disease.
Founded in 2000, Leuven-based TiGenix developes stem cell therapies for autoimmune and inflammatory diseases. These are based on expanded stem cells extracted from the patient’s adipose tissue. The company has five products in development and one on the market.
For more click here